- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06315595
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVE:
I. To study how a variety of technological approaches in MRI can be used to provide improved performance contrast-enhanced MR imaging as used for angiography and perfusion.
OUTLINE: This is an observational study. Participants are assigned to 1 of 3 groups.
GROUP 1: Participants undergo magnetic resonance imaging (MRI) on study. Participants may also undergo blood sample collection on study.
GROUP 2: Participants receive gadolinium based MR contrast agent intravenously (IV) and undergo MRI on study. Participants may also undergo blood sample collection on study.
GROUP 3: Participants receive gadolinium based MR contrast agent IV and undergo up to two MRIs on study. Participants may also undergo blood sample collection on study.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Arizona
-
Scottsdale, Arizona, United States, 85259
- Active, not recruiting
- Mayo Clinic in Arizona
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic in Rochester
-
Contact:
- Clinical Trials Referral Office
- Phone Number: 855-776-0015
-
Principal Investigator:
- Stephen J. Riederer, Ph.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults
Exclusion Criteria:
- Standard exclusion criteria for clinical MRI; e.g. cardiac pacemaker, claustrophobia, an implanted device that has been determined to be MR conditional at 1.5T but not at 3T, anticipated considerable susceptibility artifact from hip prosthesis, etc.; previous rectal surgery which may preclude tolerance of an endorectal coil
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1 (MRI)
Participants undergo MRI on study.
Participants may also undergo blood sample collection on study.
|
Non-interventional study
|
Group 2 (MRI with contrast)
Participants receive gadolinium based MR contrast agent IV and undergo a MRI on study.
Participants may also undergo blood sample collection on study.
|
Non-interventional study
|
Group 3 (MRIs with contrast)
Participants receive gadolinium based MR contrast agent IV and undergo up to two MRIs on study.
Participants may also undergo blood sample collection on study.
|
Non-interventional study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improved performance in contrast-enhanced magnetic resonance imaging (MRI) as used for angiography and perfusion
Time Frame: Baseline (at enrollment); possible second scan at a later date
|
Assessed by comparison of two images made from the raw data set but reconstructed using the standard vs. an alternative algorithm (to be determined during study).
Data will be tabulated and analyzed statistically.
|
Baseline (at enrollment); possible second scan at a later date
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Stephen J. Riederer, Ph.D., Mayo Clinic in Rochester
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-003511 (Other Identifier: Mayo Clinic Institutional Review Board)
- P30CA015083 (U.S. NIH Grant/Contract)
- NCI-2024-01895 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- R01EB031790 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Neoplasm
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedProstatic Neoplasms | Prostate Cancer | Neoplasm, Prostate | Neoplasm,ProstaticUnited States
-
University of Wisconsin, MadisonProstate Cancer Foundation; Madison Vaccines, IncCompletedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeSuspendedProstate Cancer | Prostate NeoplasmUnited Kingdom
-
Aarhus University HospitalKarolinska University Hospital; Karolinska Institutet; University of Aarhus; Central... and other collaboratorsUnknownProstate Cancer | Prostate Adenocarcinoma | Prostate NeoplasmDenmark
-
Postgraduate Institute of Medical Education and...RecruitingProstate Cancer | Prostate NeoplasmIndia
-
University College, LondonRecruitingProstate Cancer | Prostate NeoplasmUnited Kingdom
-
Crozer-Keystone Health SystemRecruitingProstate Cancer | Prostate Adenocarcinoma | Prostate NeoplasmUnited States
-
Case Comprehensive Cancer CenterNational Institutes of Health (NIH)Not yet recruitingProstate Cancer | Malignant Neoplasm of Prostate | Secondary Malignant Neoplasm of ProstateUnited States
-
University of UtahActive, not recruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Lymph Nodes | Recurrent Prostate Carcinoma | Oligometastasis | PSA FailureUnited States
Clinical Trials on Non-Interventional Study
-
Universitätsklinikum Hamburg-EppendorfSandozUnknownPsoriasisDenmark, Spain, Germany, Poland
-
University Hospital, RouenRecruitingDyspepsia | Irritable Bowel Syndrome | Functional Constipation | Faecal IncontinenceFrance
-
Mayo ClinicRecruitingOropharyngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Oropharyngeal (p16-Negative)... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Mayo ClinicRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Stage IIIA Bladder Cancer AJCC v8 | Stage II Bladder Cancer AJCC v8United States
-
Mayo ClinicRecruitingClear Cell Renal Cell Carcinoma | Urothelial Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Kidney Oncocytoma | Clear Cell Papillary Renal TumorUnited States
-
Mayo ClinicRecruitingProstate CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Mayo ClinicRecruitingBreast CarcinomaUnited States
-
Mayo ClinicRecruitingMalignant Central Nervous System NeoplasmUnited States